Thromb Haemost 1980; 43(01): 045-048
DOI: 10.1055/s-0038-1650009
Original Article
Schattauer GmbH Stuttgart

Inactivation of Human Factor VIII by Granulocyte Proteases

Katalin Váradi
The Department of Blood Coagulation, National Institute of Haematology and Blood Transfusion, Budapest, and Department of Biochemistry, University Medical School, Debrecen, Hungary
,
Katalin Marossy
The Department of Blood Coagulation, National Institute of Haematology and Blood Transfusion, Budapest, and Department of Biochemistry, University Medical School, Debrecen, Hungary
,
G Asbóth
The Department of Blood Coagulation, National Institute of Haematology and Blood Transfusion, Budapest, and Department of Biochemistry, University Medical School, Debrecen, Hungary
,
P Elödi
The Department of Blood Coagulation, National Institute of Haematology and Blood Transfusion, Budapest, and Department of Biochemistry, University Medical School, Debrecen, Hungary
,
Susan Elödi
The Department of Blood Coagulation, National Institute of Haematology and Blood Transfusion, Budapest, and Department of Biochemistry, University Medical School, Debrecen, Hungary
› Author Affiliations
Further Information

Publication History

Received 18 October 1979

Accepted 04 January 1980

Publication Date:
13 July 2018 (online)

Summary

The effect of human granulocyte proteases and related pancreatic enzymes on the procoagulant (VIII:C) and the von Willebrand (VIIIR:WF) activities of factor VIII was investigated. VIII:C appeared to be several hundred times more sensitive towards granulocyte enzymes than VIIIR: WF. The elastase-like protease (ELP) decreased both activities of factor VIII more effectively than the chymotrypsin-like enzyme (CLP). ELP increased co-operatively the inactivating effect of CLP. In the presence of a CLP-ELP mixture in a ratio of 3:1, the rate of inactivation of VIII:C was seven times as high as that with CLP alone.

Factor VIII was more resistant towards the damaging effect of pancreatic enzymes. The rate of inactivation of VIII: C was about a thousand times and that of VIIIR:WF about a hundred times lower than those measured with the related granulocyte enzymes of the same proteolytic activity. The sensitivity of VIII: C towards proteolysis was not as pronounced with pancreatic enzymes as with granulocyte proteases.

Our data suggest that, even though CLP and ELP are called "-like" enzymes, the specificity of granulocyte proteases is not identical with that of the pancreatic enzymes. The extreme sensitivity of VIII: C for granulocyte proteases may bring about blood coagulation disorders in certain pathological conditions.

 
  • References

  • 1 Weiss HJ, Kochwa S. Molecular forms of antihemophilic globulin in plasma, cryoprecipitate and after thrombin activation. Br J Haemat 1970; 18: 89-100
  • 2 Rick ME, Hoyer LW. Immunologic studies of antihaemophilic factor (AHF, Factor VIII). V. Immunologic properties of AHF subunits produced by salt dissociation. Blood 1973; 42: 737-747
  • 3 Poon MC, Ratnoff OD. Evidence that functional subunits of antihemophilic factor (factor VIII) are linked by noncovalent bonds. Blood 1976; 48: 87-94
  • 4 Elödi S, Váradi K. Optimization of conditions for the catalytic effect of the factor IXa – factor VIII complex. Probable role of the complex in the amplification of blood coagulation. Thromb Res 1979; 15: 617-629
  • 5 McKee PA, Andersen JC, Switzer ME. Molecular structural studies of human factor VIII. Ann N Y Acad Sci 1975; 240: 8-33
  • 6 Legaz ME, Weinstein MJ, Heldebrandt M, Davie EW. Isolation, subunit structure and proteolytic modification of bovine factor VIII. Ann N Y Acad Sci 1975; 240: 43-61
  • 7 Oronsky AL, Buermann CV. Phagocytic release of human leukocyte neutral proteases. Analysis of cartilage degradation products. Arch Biochem Biophys 1976; 176: 539-546
  • 8 Ohlsson K, Olsson I. The extracellular release of granulocyte collagenase and elastase during phagocytosis and inflammatory processes. Scand J Haematol 1977; 19: 145-152
  • 9 Schmidt W, Egbring R, Haveman K. Effect of elastase-like and chymotrypsin-like neutral proteases from human granulocytes on isolated clotting factors. Thromb Res 1975; 6: 315-326
  • 10 Norman PS. Studies on the plasmin system. J Exper Med, 1957; 106: 423-437
  • 11 Henson PM. The immunologic release of constituents from neutrophyl leukocytes. J Immunol 1971; 107: 535-1546
  • 12 Chordiker WB, Bock GN, Vaughan JH. Isolation of human PMN leukocytes and granules. Observation on early blood dilution and heparin. J Lab Clin Med 1968; 71: 9-19
  • 13 Feinstein G, Janoff A. A rapid method for purification of human granulocyte cationic neutral proteases: purification and characterization of human granulocyte chymotrypsin-like enzyme. Biochim Biophys Acta 1975; 403: 477-492
  • 14 Baugh RJ, Travis J. Human leukocyte granule elastase: rapid isolation and characterization. Biochemistry 1976; 15: 836-841
  • 15 Newman J, Johnson AJ, Karpatkin MH, Puszkin S. Method for the production of clinically effective intermediate and high-purity factor VIII concentrates. Br J Haematol 1971; 21: 1-20
  • 16 Van Mourik JA, Mochtar IA. Purification of human antihaemophilic factor (factor VIII) by gel chromatography. Biochim Biophys Acta 1970; 221: 677-679
  • 17 Elödi S, Váradi K, Hollán SR. Some sources of error in the one-stage assay of factor VIII. Haemostasis 1978; 7: 1-9
  • 18 MacFarlane DE, Stibbe J, Kirby EP, Zucker MB, Grant RA, McPherson J. A method for assaying von Willebrand factor (Ristocetin cofactor). Thromb Diath Haemorrh 1975; 34: 306-308
  • 19 Stibbe J, Kirby EP. The influence of Haemacell, fibrinogen and albumin on Ristocetin-induced platelet aggregation. Relevance to the quantitative measurement of Ristocetin Cofactor. Thromb Res 1976; 8: 151-165
  • 20 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem, 1951; 193: 265-275
  • 21 Sodetz JM, Paulson JC, Pizzo SV, McKee PA. Carbohydrate of human factor VIII (von Willebrand factor). Impairment of function by removal of specific galactose residues. J Biol Chem 1978; 253: 7202-7206
  • 22 Guisasola JA, Cockburn CG, Hardisty RM. Plasmin digestion of factor VIII: characterization of the breakdown products with respect to antigenicity and von Willebrand activity. Thromb. Haemost 1978; 40: 302-315
  • 23 Gralnick HR, Morisato DK. The importance of carbohydrate moiety of the factor VIII (von Willebrand factor) protein in binding to and causing agglutination of human platelets. Thromb Haemost 1979; 42: 372 Abstr. VIIth International Congress on Thrombosis and Haemostasis, London, 15-20, July 1979
  • 24 Blow AM J. Action of human lysosomal elastase on the oxidized B chain of insulin. Biochem J 1977; 161: 13-16
  • 25 Blow AM J, Barrett AJ. Action of human cathepsin G on the oxidized B chain of insulin. Biochem J 1977; 161: 17-19
  • 26 Taylor JC, Crawford IP. Purification and preliminary characterization of human leukocyte elastase. Arch Biochem Biophys 1975; 169: 91-101
  • 27 Egbring R, Schmidt W, Fuchs G, Haveman K. Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects. Blood 1977; 49: 219-231